The U.S. Food and Drug Administration approved Rasonque (daraxonrasib) on Wednesday, August 26, 2026. The decision came 6.5 months in advance of the PDUFA date and marks a historic milestone
The U.S. Food and Drug Administration approved Rasonque (daraxonrasib) on Wednesday, August 26, 2026. The decision came 6.5 months in advance of the PDUFA date and marks a historic milestone
“Supply Chain Logistics For A PET Radiotracer Manufacture”
Supply chain for an 18F radioisotope based PET radiotracer manufacture is discussed in detail along with brief manufacturing descriptions provided for context. A critical report for supply chain, manufacturing, business and investing personnel to familiarize with the basics of supply chain for this category of high application, commercially critical PET diagnostic imaging agents.
Click the icon below to download the eReport.
